Canada markets open in 6 hours 26 minutes

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0376+0.0001 (+0.27%)
At close: 02:23PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.76M
Enterprise Value 1.16M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.29k
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.90k
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3-85.65%
S&P500 52-Week Change 321.08%
52 Week High 30.2760
52 Week Low 30.0210
50-Day Moving Average 30.0399
200-Day Moving Average 30.0592

Share Statistics

Avg Vol (3 month) 3108.99k
Avg Vol (10 day) 358.22k
Shares Outstanding 5100.08M
Implied Shares Outstanding 6100.08M
Float 864.07M
% Held by Insiders 135.89%
% Held by Institutions 10.01%
Shares Short (Sept 15, 2023) 42.69M
Short Ratio (Sept 15, 2023) 40.52
Short % of Float (Sept 15, 2023) 43.96%
Short % of Shares Outstanding (Sept 15, 2023) 42.68%
Shares Short (prior month Aug 15, 2023) 4534.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 26, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 26, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,678,791.02%

Management Effectiveness

Return on Assets (ttm)-107.05%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)610
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.13M
Net Income Avi to Common (ttm)-8.81M
Diluted EPS (ttm)-0.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.86M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)1.26M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.56
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-9.71M
Levered Free Cash Flow (ttm)-7.77M